Polyclonal Rabbit anti‑Human AOAH / Acyloxyacyl Hydrolase Antibody (Biotin, aa24‑300, WB) LS‑C689181
Polyclonal Rabbit anti‑Human AOAH / Acyloxyacyl Hydrolase Antibody (Biotin, aa24‑300, WB) LS‑C689181
Antibody:
AOAH / Acyloxyacyl Hydrolase Rabbit anti-Human Polyclonal (aa24-300) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
AOAH / Acyloxyacyl Hydrolase Rabbit anti-Human Polyclonal (aa24-300) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
Acyloxyacyl Hydrolase antibody LS-C689181 is a biotin-conjugated rabbit polyclonal antibody to Acyloxyacyl Hydrolase (AOAH) (aa24-300) from human. It is reactive with human and pig. Validated for WB.
Target
Human AOAH / Acyloxyacyl Hydrolase
Synonyms
AOAH | Acyloxyacyl hydrolase
Reactivity
Human, Pig
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant AOAH (Ser24-Gln300)
Specificity
The antibody is a rabbit polyclonal antibody raised against AOAH.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About AOAH / Acyloxyacyl Hydrolase
Featured Products
Species:
Human, Mouse
Applications:
Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot, ELISA
Reactivity:
Human
Range:
0.156-10 ng/ml
Source:
E. coli
Tag:
His-S
Reactivity:
Human
Range:
78.125-5000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/24/2024